Evonik to invest $220M in Lafayette lipid production expansion

Evonik announced plans to invest $220 million to expand operations in Lafayette, Indiana, adding a new factory to produce lipids for mRNA-based medicines. The project will create up to 80 jobs, with construction starting in 2023 and completion in 2025.

“Evonik’s strategic expansion at Tippecanoe is fantastic news for the entire Greater Lafayette region.”thecentersquare.com

• 2 sources
• thecentersquare.comBiomed company Evonik to invest $220M in Lafayette expansion, receive $155M in incentives | Indiana | thecentersquare.comLawrence Wilson, The Center Square contributorJun 8, 2022
• buildingindiana.comGerman Life Sciences Company Investing $220M - Building Indiana BusinessNews ReleaseJun 27, 2022

Summarized from public sources; check the original articles before acting on it.